Konstantinos Drosatos is an Assistant Professor of Pharmacology at Temple University, with expertise in molecular biology, metabolism of lipids, hyperlipidemia, heart failure and sepsis.

Drosatos has roots in Partheni of Evia.

He received his BS in Biology from the Aristotle University of Thessaloniki, his MSc and PhD in Molecular Biology and Biomedicine from the University of Crete and Boston University and later was named Postdoctoral Research Scientist at Columbia University.

His research aims to elucidate the mechanisms that underlie sepsis-induced cardiac energy deprivation and coordinate with clinical scientists to propose potential treatments for improvement of heart function in septic patients. The findings of his studies can be extrapolated to other types of cardiac dysfunction and propose novel therapies for the treatment of heart failure. In addition, he is exploring the cardiac metabolic profile and its contribution in the phenotype of other diseases, such as the Spinal Muscular Atrophy (SMA).

He is member of the American Heart Association, the Council on Basic Cardiovascular Sciences, the International Society for Heart Research, the World Hellenic Biomedical Association and the Hellenic Bioscientific Association in the USA.

In 2004 Drosatos and his colleagues Dimitris Iliopoulos, Iordanis Karagiannidis and Thomas Thomou founded the Hellenic Bioscientific Association in the USA. Currently, HBA-USA encompasses over 400 members, US based Greek-American scientists and researchers. In fact, HBA-USA regurarly collaborates with the Aristotle University of Thessaloniki and the University of Ioannina.